0.4341
Precedente Chiudi:
$0.418
Aprire:
$0.404
Volume 24 ore:
141.84K
Relative Volume:
0.87
Capitalizzazione di mercato:
$39.33M
Reddito:
$8.90M
Utile/perdita netta:
$-4.57M
Rapporto P/E:
-7.8076
EPS:
-0.0556
Flusso di cassa netto:
$-1.84M
1 W Prestazione:
-7.42%
1M Prestazione:
-8.61%
6M Prestazione:
+46.66%
1 anno Prestazione:
-25.81%
Milestone Scientific Inc. Stock (MLSS) Company Profile
Nome
Milestone Scientific Inc.
Settore
Industria
Telefono
973-535-2717
Indirizzo
220 South Orange Avenue, Livingston, NJ
Compare MLSS vs ISRG, BDX, ALC, RMD, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
MLSS
Milestone Scientific Inc.
|
0.4341 | 37.88M | 8.90M | -4.57M | -1.84M | -0.0556 |
|
ISRG
Intuitive Surgical Inc
|
360.46 | 124.79B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
176.42 | 48.98B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
66.55 | 33.08B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
RMD
Resmed Inc
|
219.58 | 31.73B | 5.54B | 1.52B | 1.74B | 10.37 |
|
MDLN
Medline Inc
|
32.39 | 29.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
Milestone Scientific Inc. Stock (MLSS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-09-16 | Iniziato | Northland Capital | Market Perform |
| 2018-11-16 | Reiterato | Maxim Group | Buy |
| 2016-12-23 | Reiterato | Maxim Group | Buy |
| 2015-12-11 | Iniziato | Maxim Group | Buy |
Milestone Scientific Inc. Borsa (MLSS) Ultime notizie
Core Scientific Wins Conditional ERCOT Approval for 1,402 Megawatts in Texas - Minichart
Milestone Scientific (NYSE: MLSS) opens path to raise up to $45M - Stock Titan
Milestone Scientific Earnings Call Highlights CompuFlo Surge - TipRanks
Milestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three Directors - Moomoo
Earth’s oceans reach a milestone scientists say may be unprecedented in millennia - yahoo.com
Milestone Scientific Q2 revenue up 22%; affirms FY26 guidance - scanx.trade
Benchmark reiterates Speculative Buy on Milestone Scientific stock By Investing.com - Investing.com Australia
MLSS Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Cost Discipline Despite Revenue UncertaintyNon-GAAP Earnings - vinanet.vn
Benchmark reiterates Speculative Buy on Milestone Scientific stock - Investing.com
Transcript: Milestone Scientific Q2 2026 Earnings Conference Call - Sahm
Milestone Scientific’s Global Exposure: Geopolitical and China Risks Threaten Supply Chain and Revenue - TipRanks
Milestone Scientific Inc (MLSS) (Q2 2026) Earnings Call Highligh - GuruFocus
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Milestone Scientific Releases Q2 2026 Financial Results - news.alphastreet.com
Milestone Scientific Q3 Sales Guidance Misses $2.510M Estimate - scanx.trade
Earnings call transcript: Milestone Scientific posts Q2 2026 revenue growth By Investing.com - Investing.com India
MLSS: Q2 revenue up 22% year-over-year, medical segment surges, 2026 guidance reaffirmed - TradingView
Earnings call transcript: Milestone Scientific posts Q2 2026 revenue growth - Investing.com
Milestone Scientific Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com
Milestone Scientific Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Milestone Scientific Reports 231% Growth in Medical Revenue, Announces VA and DoD Distribution Agreement and Reaffirms 2026 Outlook - Quiver Quantitative
Milestone Scientific Reports Financial Results for Second Quarter 2026 - marketscreener.com
Press Release: Milestone Scientific Reports Financial Results for Second Quarter 2026 - Moomoo
Milestone Scientific (NYSE: MLSS) grows revenue 22% but flags going concern risk - Stock Titan
Milestone Scientific Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Earnings To Watch: Milestone Scientific Inc (MLSS) Q2 2026 -- GF Value Sees 13% Upside - Yahoo Finance
What To Expect From Milestone Pharmaceuticals Inc (MIST) Q2 2026 Earnings - Yahoo Finance
Milestone Scientific (MLSS) Advances 3.01% to $0.48, Approaching Key $0.50 ResistanceWide Range Bar - dars.gov.et
Milestone Scientific to host Q2 earnings conference call - Bitget
Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call - The Manila Times
Computerized drug-delivery developer sets Aug. 14 results call - Stock Titan
Milestone Scientific schedules Q2 2026 earnings call for August 14 to discuss financial results and corporate updates. - Pluang
Milestone Scientific (MLSS) Inches Higher to $0.46 as Consolidation ContinuesProtective Put - vinanet.vn
Milestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System - The Manila Times
Epidural Device to Be Marketed Across VA and Military Systems - Stock Titan
Milestone Scientific signs federal distribution deal with Red One - scanx.trade
Milestone Scientific Shareholders Approve Governance and Equity Changes - TipRanks
Milestone Scientific Inc. (NYSE: MLSS) investors back higher share and equity plan limits - Stock Titan
Milestone Scientific, Inc. Revenue Breakdown – AMEX:MLSS - TradingView
Milestone Scientific Directors Elect Conversion of Bridge Notes - TipRanks
Milestone Scientific directors elect conversion of remaining bridge notes pending $0.50 fair value - TradingView
Milestone Scientific Inc. (MLSS) Gains 3.13% as Stock Tests Key Resistance at $0.42BPI Bull Confirmed - dars.gov.et
Milestone Scientific Inc (MLSS) Cash Flow - TradingKey
Milestone Scientific Inc (MLSS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TradingKey - TradingKey
Milestone Scientific Inc (MLSS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Milestone Scientific Inc (MLSS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Milestone Scientific Inc (MLSS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MLSS|Milestone Scientific Inc|Price:0.390|Chg%:-0.008 - TradingKey
MLSS|Milestone Scientific Inc|Price:0.414|Chg%:+0.024 - TradingKey
MLSS Q1 2026 Earnings: Improved Loss Per Share Beats Estimates, Stock Gains 4%Earnings Analysis - vinanet.vn
Milestone Scientific Inc. Azioni (MLSS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):